Compass Ion Advisors’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$498K Sell
730
-7
-0.9% -$4.84K 0.05% 178
2025
Q4
$420K Buy
737
+13
+2% +$7.54K 0.04% 191
2025
Q3
$441K Buy
724
+3
+0.4% +$1.7K 0.04% 188
2025
Q2
$361K Buy
721
+2
+0.3% +$983 0.04% 195
2025
Q1
$368K Buy
719
+2
+0.3% +$955 0.04% 192
2024
Q4
$337K Buy
717
+2
+0.3% +$1.01K 0.04% 200
2024
Q3
$378K Sell
715
-35
-5% -$17.1K 0.05% 191
2024
Q2
$359K Hold
750
0.05% 169
2024
Q1
$359K Sell
750
-61
-8% -$28.1K 0.05% 169
2023
Q4
$380K Sell
811
-5
-0.6% -$2.34K 0.06% 161
2023
Q3
$359K Buy
816
+365
+81% +$160K 0.06% 159
2023
Q2
$206K Buy
451
+2
+0.4% +$907 0.05% 77
2023
Q1
$208K Buy
449
+1
+0.2% +$464 0.05% 71
2022
Q4
$244K Sell
448
-133
-23% -$69.4K 0.06% 62
2022
Q3
$273K Buy
581
+2
+0.3% +$953 0.08% 56
2022
Q2
$277K Buy
579
+2
+0.3% +$918 0.08% 61
2022
Q1
$258K Buy
577
+2
+0.3% +$826 0.08% 73
2021
Q4
$223K Buy
575
+2
+0.3% +$745 0.07% 86
2021
Q3
$206K Buy
573
+3
+0.5% +$1.08K 0.07% 88
2021
Q2
$207K Buy
+570
New +$205K 0.08% 83

Other funds holding NOC

Compass Ion Advisors's NOC Position: Q1 2026 in Review

Compass Ion Advisors reduced its Northrop Grumman (NOC) stake by 0.95% in Q1 2026, selling an estimated $4.84K and leaving 730 shares worth $498K. The position accounts for 0.05% of the portfolio, ranked #178.

Compass Ion Advisors first reported a position in NOC in Q2 2021 and has held it in 20 quarters since. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Compass Ion Advisors held 730 shares of Northrop Grumman worth $498K as of Q1 2026.
  • Compass Ion Advisors sold 7 Northrop Grumman shares in Q1 2026, an estimated $4.84K.
  • Northrop Grumman made up 0.05% of Compass Ion Advisors's portfolio in Q1 2026, its #178 holding.
  • Compass Ion Advisors first reported a position in Northrop Grumman in Q2 2021 and has held it in 20 quarters since.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Compass Ion Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.